|
Dr. Renee Demarest Dr. Demarest received her Ph.D. in Molecular Biology and Genetics from Temple University School of Medicine in 2005. Her graduate work consisted of studying cyclin T1 regulation during primary human T-cell activation. Cyclin T1 is a cellular factor required for replication of HIV. During this period she received The Distinguished University Fellowship and a Predoctoral Traineeship Award from the Department of Defense Breast Cancer Research Program. Since 2005, Dr. Demarest has worked as a postdoctoral fellow studying the role of Notch in leukemogenesis in the laboratory of Dr. Anthony Capobianco at The Wistar Institute. She is supported by a fellowship from The National Cancer Institute Training Program in Basic Cancer Research. Dr. Demarest’s graduate and post-doctoral training has been primarily in Cancer Biology, with particular emphasis on cellular signaling. She is proficient in cellular and mouse models of cancer biology. Her technological experience includes all major molecular biology techniques, including Western, Northern and Southern blot analyses, RT-PCR, Real-Time PCR, miRNA identification and validation, Immunoprecipitation, Immunohistochemistry, microarray sample preparation and analysis, cloning, lentiviral and retroviral vector construction and infection, Chromatin Immunoprecipitation (ChIP), and kinase assays. She has extensive experience writing and peer reviewing manuscripts. Additionally, she has successfully written NIH R01 grants and numerous fellowships, and has been extensively trained and participated in reviewing these applications. Currently, Dr. Demarest is completing her post-doctoral studies at The Wistar Institute and is beginning her search for an independent position. |